Zhijun Zhou

2 ta ish

Institute of Nuclear Medicine

1. Structural Optimization of Fibroblast Activation Protein Inhibitors Through Zwitterionic and PEG Modification Strategy: Impact on Pharmacokinetics and Tumor Imaging

   Hongmei Yuan, Haiyang Li, Tongtong Wu +8

   MaqolaPeptidase Inhibition and AnalysisMolecular Pharmaceutics20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000352

2. Novel Covalent FAP-Targeted [ ⁶⁸ Ga]Ga-DOTA-mFS-KERERG-FAP-2286 for Improved Pharmacokinetics and Enhanced Tumor Uptake

   Zhongcai Jin, Tongtong Wu, Shijie Tang +12

   MaqolaPeptidase Inhibition and AnalysisMolecular Pharmaceutics20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.014250